USE OF THE SOLUBLE FORM OF AXL IN THE DIAGNOSIS ANDOR PROGNOSIS OF HEART FAILURE SYNDROME USE OF THE SOLUBLE FORM OF AXL IN THE DIAGNOSIS ANDOR PROGNOSIS OF HEART FAILURE SYNDROME
USE OF THE SOLUBLE FORM OF AXL IN THE DIAGNOSIS ANDOR PROGNOSIS OF HEART FAILURE SYNDROME USE OF THE SOLUBLE FORM OF AXL IN THE DIAGNOSIS ANDOR PROGNOSIS OF HEART FAILURE SYNDROME
Use of thiol redox proteins for reducing protein intramolecular disulfide bonds for improving the quality of cereal products dough and baked goods and for inactivating snake bee and scorpion toxins Use of thiol redox proteins for reducing protein intramolecular disulfide bonds for improving the quality of cereal products dough and baked goods and for inactivating snake bee and scorpion toxins
USE OF TYPE II PNEUMOCYTES IN THE TRATMENT OF PULMONARY DISEASES USE OF TYPE II PNEUMOCYTES IN THE TRATMENT OF PULMONARY DISEASES
Use of 25dihydroxybenzene derivatives for the treatment of angiogenic diseases Use of 25dihydroxybenzene derivatives for the treatment of angiogenic diseases
Use of 25dihydroxybenzene sulfonic acid derivatives for the treatment of arthritis and pain Use of 25dihydroxybenzene sulfonic acid derivatives for the treatment of arthritis and pain
Use of 25dihydroxybenzene sulfonic acid derivatives for the treatment of tissue reactive diseases Use of 25dihydroxybenzene sulfonic acid derivatives for the treatment of tissue reactive diseases
USE OF 5CARBOXYMETHYL3MERCAPTO124TRIAZINO56B INDOLES AND THEIR PHARMACEUTICAL COMPOSITION USE OF 5CARBOXYMETHYL3MERCAPTO124TRIAZINO56B INDOLES AND THEIR PHARMACEUTICAL COMPOSITION
USE OF 5CARBOXYMETHYL3MERCAPTO124TRIAZINO56B INDOLES AND THEIR PHARMACEUTICAL COMPOSITION USE OF 5CARBOXYMETHYL3MERCAPTO124TRIAZINO56B INDOLES AND THEIR PHARMACEUTICAL COMPOSITION